bioMérieux stock breaks through its 75.80 € resistance level and rebounds by more than 3%
bioMérieux stands out as one of the rare equities resisting the general decline in European markets this Thursday, pushing its price beyond a technical threshold it had already tested in early September. The move comes on the same day as the commercial launch of Spinchip, a rapid testing platform intended for emergency services, and a confirmation of an analyst's opinion.
A breakthrough of the 75.80 € resistance placing the security among the strongest gains of the SBF 120
bioMérieux gains 3.27% to 77.35 € during the session, ranking among the strongest increases of the SBF 120 while the index declines 0.26%. The security has broken upward through its 75.80 € resistance and is maintaining it, extending a movement already initiated in early September: the 75.80 € threshold had then been briefly touched before the security returned below this level. This time, the maintenance above appears more solid, especially as the price now exceeds its 20-day (73.24 €) and 50-day (72.78 €) moving averages with respective gaps of 5.61% and 6.28%.
The 200-day MA, at 84.20 €, remains nevertheless above the current price. The RSI at 59 reflects genuine buying momentum, without reaching the overbought zone. Over the week, the security advances 6.76%, and 16.14% over three months, which contrasts with a decline of 32.27% over one year.
The launch of Spinchip and a maintained analyst opinion at buy with 100 € target gives substance to the rebound
The fundamental context of the day provides dual support for the movement. bioMérieux presented this Thursday its Spinchip platform, a troponin test achievable in ten minutes in emergency departments, one year after the acquisition of Norwegian company Spinchip Diagnostics. This launch is part of the group's GO-28 strategic plan, which aims for organic revenue growth of between 3% and 5% for the 2026 fiscal year, according to the outlook communicated when publishing first-half results on August 4, 2026. In parallel, CIC Market Solutions confirmed today its buy opinion on the security with a price target maintained at 100 €, representing an upside potential of nearly 29% compared to the current price. The analysts' view thus aligns with today's technical momentum. The next level to watch remains the 101 € resistance, a threshold the group has not revisited in several months.
